Then the combination of heteronemin and tetrac (or NDAT) downregulates EGFR/STAT3 expressions and cell motility in KRAS mutated A549 non-small cell lung cancer (NSCLC) cells [12]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.